March 14, 2018

NANOTECHNOLOGY DELIVERS A TWO-PUNCH COMBINATION WITH BIG POTENTIAL FOR PATIENTS WITH RARE CANCERS

Researchers at the Endocrine Oncology Branch of the National Cancer Institute (NCI) reported in the latest edition of the Journal of the National Cancer Institute (JNCI) that they were able to safely and effectively deliver a next-generation nanomedicine to mice with metastatic thyroid cancers and pancreatic neuroendocrine tumors (PNETs).

Read the full release on site

Read the full release on PR Newswire